KANEKA CORPORATION will present its innovative affinity chromatography resins, KANEKA KanCap™ series, the best solution for purifying all types and formats of monoclonal antibodies, from classical full length, to fragmented and engineered formats such as bispecific and Fc-fusion proteins. For more information, please visit our booth and our website at www.bioseparation.kaneka.com
KANEKA CORPORATION, Japan is a 548 billion yen producer in 9 businesses fields including pharma region. We have long experience and worldwide network in this business field and enjoy good reputation about quality, reliability, and innovation. Based on our innovation, we have developed and supplied a lot of products such as small molecule pharmaceuticals, peptide synthetic reagents, generic APIs, transdermal medical products, site-selective bioconjugation and so on.